September 24, 2014 / 2:23 PM / 3 years ago

BUZZ-Valeant Pharmaceuticals: Estimates strong Q3 results

** Canadian drugmaker’s shares up about 5.4 pct at C$135.15

** Company’s U.S.-listed shares up about 5 percent at $121.71

** Says it estimates Q3 revenue above Street expectations

** Says expects overall Q3 same-store organic growth to be more than 15 pct

** Says adjusted profit to come in above its own forecast

** Up to Tuesday’s close of C$128.29, company’s Toronto-listed shares had fallen nearly 8 percent since April 21, when Valeant teamed up with activist-investor William Ackman to buy botox-maker Allergan Inc

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below